David Zawitz - 09 Dec 2024 Form 4 Insider Report for Verrica Pharmaceuticals Inc. (VRCA)

Role
Chief Operating Officer
Signature
/s/ Christopher Hayes, Attorney-in-Fact
Issuer symbol
VRCA
Transactions as of
09 Dec 2024
Net transactions value
$0
Form type
4
Filing time
09 Dec 2024, 17:18:25 UTC
Next filing
25 Nov 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRCA Employee Stock Option (right to buy) Award $0 +950,000 $0.000000 950,000 09 Dec 2024 Common Stock 950,000 $0.9500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/8th of the total shares subject to the option shall vest on June 9, 2025, and 1/48th of the total shares subject to the option shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continuous service through such vesting date.